Institute of Neurobiology and Molecular Medicine, National Research Council (CNR), via Fosso del Cavaliere, Vermicino, Roma, Italy.
Curr Stem Cell Res Ther. 2010 Dec;5(4):314-25. doi: 10.2174/157488810793351659.
The discovery of several sources of hepatic progenitors in extra-hepatic organs and tissues, both in animal models and in humans, supports opportunities to isolate, grow and expand them in vitro. Microenvironment factors involved in regulating proliferation and commitment of liver cell precursors have been identified and better characterization of liver stem cell pathobiology would greatly improve the understanding of liver differentiation/ regeneration processes, especially those leading to hepatocarcinogenesis. The goal of these researches has been to discover the most available, suitable and easy-to-use pluripotent stem cells (PSC) sources for cell-based therapies in genetic and acquired liver diseases, therapies which to date have required liver transplantation. This report reviews the efforts, so far, to either investigate the presence of PSC in hepatic and extra-hepatic districts or evaluate their capacity to differentiate in vitro and to restore in vivo liver function.
在动物模型和人类中,已经发现了几种肝祖细胞在肝外器官和组织中的来源,这为它们在体外的分离、培养和扩增提供了机会。已经鉴定出参与调节肝前体细胞增殖和定向分化的微环境因素,更好地阐明肝干细胞的病理生物学特性将极大地促进对肝分化/再生过程的理解,特别是那些导致肝癌发生的过程。这些研究的目标是发现最可用、最合适和最易于使用的多能干细胞(PSC)来源,用于遗传和获得性肝脏疾病的细胞治疗,迄今为止,这些疾病需要进行肝移植。本报告综述了迄今为止在肝内和肝外区域探索 PSC 存在的情况,或评估其在体外分化和恢复体内肝功能的能力的努力。